查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1503440

到 2030 年醫療食品市場預測：按產品、給藥途徑、銷售管道、營養成分、形式、年齡層、應用和地區進行全球分析

Medical Foods Market Forecasts to 2030 - Global Analysis By Product, Route of Administration, Sales Channel, Nutritional Ingredient, Form, Age Group, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2024 年全球醫療食品市場價值為 276.2 億美元，預計在預測期內將以 8.2% 的複合年成長率成長，到 2030 年將達到 443.1 億美元。

醫療食品是專門為疾病和病症的飲食管理而配製的產品，這些疾病和病症具有獨特的營養需求，僅靠常規飲食無法滿足。與膳食食品不同，醫用食品需要在醫療監督下使用，通常用於特定的醫療狀況，例如代謝紊亂、胃腸道疾病或神經系統疾病。醫療食品是根據科學原理配製的，以確保您根據個人情況獲得所需的準確營養量。

據世界衛生組織 (WHO) 稱，2015 年至 2050 年間，全球 60 歲及以上人口預計將加倍，從 12% 增至 22%。根據國際糖尿病聯盟的數據，2019 年約有 4.63 億成年人患有糖尿病，預計到 2045 年將增加至 7 億。

代謝性疾病增加

糖尿病、苯酮尿症和各種先天性代謝缺陷等代謝性疾病的增加正在顯著推動醫療食品市場的成長。這些疾病需要精確的飲食管理來控制症狀並預防併發症，從而增加了對專門為滿足受影響個體的營養需求而設計的醫療食品的需求。此外，醫療保健專業人員和患者對營養在代謝紊亂管理中的作用的認知不斷提高，也有助於醫療食品市場的擴大。

認知和採用有限

認知和採用有限是醫療食品市場的主要限制。許多醫療保健專業人員和患者經常對什麼是醫療食品、它們與常規食品和藥物有何不同以及醫療食品在治療慢性疾病和醫療狀況方面的具體用途感到困惑。這種認知的缺乏可能會導致利用不足和懷疑，因為醫用食品通常需要醫療監督並遵守嚴格的使用指南。此外，教育和行銷力度不足也導致採用率低。

個人化營養

醫療食品市場透過根據個人健康需求客製化飲食干預措施，為個人化營養提供了重要機會。個人化營養著重於根據人的遺傳、微生物組、生活方式和健康狀況開發客製化飲食。這種方法可以加強慢性病管理，改善患者的治療效果，並滿足特定的代謝需求。隨著醫療保健日益轉向精準醫療，個人化醫療食品可以提供有針對性的營養解決方案，以減少對藥物的依賴並最佳化整體健康。

市場競爭

醫療食品市場面臨多方面的重大市場競爭威脅。製藥公司憑藉先進的治療營養產品進入該領域也將加劇競爭。此外，功效聲明所需的臨床試驗的成本和複雜性也是新參與企業的障礙。監管變化和不斷變化的報銷政策可能會影響市場動態，有利於能夠快速適應的現有企業。開發獨特且有針對性的配方的創新壓力也加劇了競爭。

COVID-19 的影響：

COVID-19 大流行在多個方面對醫療食品市場產生了重大影響。隨著健康意識的增強，對支持免疫健康和整體健康的產品的需求激增。此外，全球供應鏈的中斷正在為原料採購和製造帶來挑戰。然而，電子商務平台和線上零售的進步在一定程度上緩解了這些挑戰，使消費者能夠更方便地獲得醫療食品。

維生素和礦物質行業預計將在預測期內成為最大的行業

醫療食品市場維生素和礦物質部分的成長主要是由於人們對營養缺乏及其對健康影響的認知不斷提高而推動的。隨著人們健康意識的增強，對針對特定健康狀況的有針對性的營養解決方案的需求不斷成長。維生素和礦物質在支持多種身體功能方面發揮著重要作用，使其成為治療營養不良、代謝紊亂和慢性疾病等疾病的醫療食品的重要成分。此外，研究和開發的進步導致了專門產品的配方以滿足特定的營養需求，進一步推動了該領域的成長。

預計慢性病產業在預測期間內複合年成長率最高

醫療食品市場慢性病部分的成長歸因於多種因素。糖尿病、心血管疾病和胃腸道疾病等慢性病的盛行率日益增加，推動了對專門營養品的需求，以有效管理這些疾病。醫學研究的進步導致了專門為滿足慢性病患者的營養需求而設計的創新配方的開發。此外，醫療保健專業人員和患者對營養在慢性病管理中的作用的認知不斷提高，正在推動市場擴張。

比最大的地區

近年來，北美醫療食品市場經歷了顯著成長。這種擴張是由於多種因素造成的，包括人們越來越認知到營養療法在治療糖尿病、阿茲海默症和代謝紊亂等慢性疾病中的重要性。此外，醫學研究和技術的進步也促進了針對特定健康狀況的創新醫療食品的開發。此外，北美的老齡化人口正在增加對支持健康老化和管理與老齡化相關疾病的產品的需求。

複合年成長率最高的地區：

由於多種因素，亞太地區醫療食品市場正在經歷顯著成長。人們對健康和營養意識的提高、慢性病盛行率的增加以及人口老化正在推動對特種營養產品的需求。此外，醫療保健基礎設施的進步和可支配收入的增加正在促進更多人獲得醫療食品。此外，該地區多樣化的飲食習慣和文化偏好鼓勵產品開發創新，以滿足特定的飲食需求。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球醫療食品市場：依產品

  • 口服補液溶液
  • 營養全面的配方
  • 配方營養不完整

第6章 全球醫療食品市場：依管理途徑

  • 口服
  • 腸內

第7章全球醫療食品市場：依銷售管道

  • 超級市場/大賣場
  • 零售藥房
  • 藥局
  • 網上銷售
  • 企業銷售（醫院藥局）

第8章全球醫療食品市場：依營養成分分類

  • 蛋白質
  • 維生素和礦物質
  • 異黃酮
  • Omega-3
  • 植物固醇

第9章全球醫療食品市場：依形狀分類

  • 酒吧
  • 凝膠
  • 液體
  • 粉末
  • 錠劑/膠囊
  • 其他形狀

第10章全球醫療食品市場：依年齡層別

  • 成人
  • 青春期
  • 斷乳期
  • 嬰兒

第11章全球醫療食品市場：依應用分類

  • 睡眠管理
  • 神經退化性疾病
  • 楓糖尿症(MSUD)
  • 糖尿病（糖尿病神經病變）
  • 癌症（化療引起的腹瀉）
  • 注意力不足過動症（ADHD）
  • 阿茲海默症
  • 慢性疾病
  • 憂鬱症
  • 先天性代謝缺陷
  • 輕度肝性腦病變
  • 神經/心理疾病
  • 營養不良
  • 肥胖/高血壓
  • 眼科
  • 病原體相關感染疾病
  • 尿素循環障礙
  • 罕見疾病
    • 嗜伊紅性食道炎
    • 苯酮尿症
    • 食物蛋白誘發的小腸結腸炎症候群 (FPIES)
  • I/II型酪胺酸血症
  • 丙酸血症
  • 疼痛管理
  • 有機酸尿症
  • 甲基丙二酸血症
  • 異戊酸血症
  • 高胱氨酸尿症
  • 胃腸道疾病

第12章全球醫療食品市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東/非洲

第13章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購/合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第14章 公司概況

  • Abbott Laboratories
  • Ajinomoto Cambrooke Inc
  • Alfasigma SpA
  • BioMarin Pharmaceutical
  • Cerecin Inc
  • Danone SA
  • Fresenius SE & Co. KGaA
  • Mead Johnson
  • Meiji Holdings and Co Ltd
  • Metagenics Inc
  • Nestle SA
  • Primus Pharmaceuticals Inc
  • Reckitt Benckiser Group plc
Product Code: SMRC26611

According to Stratistics MRC, the Global Medical Foods Market is accounted for $27.62 billion in 2024 and is expected to reach $44.31 billion by 2030 growing at a CAGR of 8.2% during the forecast period. Medical foods are specially formulated products intended for the dietary management of diseases or conditions with distinctive nutritional needs that cannot be met by a normal diet alone. Unlike dietary supplements, medical foods are meant to be used under medical supervision and are often used for specific conditions like metabolic disorders, gastrointestinal diseases, or neurological disorders. They are formulated based on scientific principles to provide essential nutrients in precise amounts, tailored to the individual's condition.

According to the World Health Organization, the global population of people aged 60 and over is expected to double from 12 percent to 22 percent between 2015 and 2050. According to the International Diabetic Federation, around 463 million adults have diabetes in 2019, with this figure expected to climb to 700 million by 2045.

Market Dynamics:

Driver:

Rise in metabolic disorders

The rise in metabolic disorders, such as diabetes, phenylketonuria, and various inborn errors of metabolism, is significantly driving the growth of the medical food market. As these conditions require precise dietary management to control symptoms and prevent complications, there is an increasing demand for specialized medical foods designed to meet the nutritional needs of affected individuals. Additionally, greater awareness among healthcare professionals and patients about the role of nutrition in managing metabolic disorders contributes to the expanding market for medical foods.

Restraint:

Limited awareness and adoption

In the medical food market, limited awareness and adoption are significant restraints. Many healthcare professionals and patients are unfamiliar with what medical foods are, how they differ from regular foods and drugs, and their specific applications in managing chronic diseases or conditions. This lack of awareness can lead to underutilization and skepticism, as medical foods often require medical supervision and adherence to strict usage guidelines. Additionally, inadequate education and marketing efforts contribute to a slow adoption rate.

Opportunity:

Personalized nutrition

The medical food market offers significant opportunities in personalized nutrition by tailoring dietary interventions to individual health needs. Personalized nutrition focuses on developing customized diets based on a person's genetics, microbiome, lifestyle, and health conditions. This approach can enhance the management of chronic diseases, improve patient outcomes, and cater to specific metabolic requirements. As healthcare increasingly shifts towards precision medicine, personalized medical foods can provide targeted nutritional solutions, reducing reliance on pharmaceuticals and optimizing overall health.

Threat:

Market competition

The medical foods market faces significant market competition threats from several angles. Pharmaceutical companies entering the space with advanced therapeutic nutrition products also heighten competition. Additionally, the cost and complexity of clinical trials required for efficacy claims create barriers for new entrants. Regulatory changes and evolving reimbursement policies can impact market dynamics, favoring established players who can quickly adapt. Innovation pressure to develop unique, targeted formulations adds another layer of competitive intensity.

Covid-19 Impact:

The COVID-19 pandemic has significantly impacted the medical food market in several ways. With increased awareness of health and wellness, there has been a surge in demand for products that support immune health and overall well-being. Furthermore, disruptions in the global supply chain have led to challenges in sourcing ingredients and manufacturing. However, advancements in e-commerce platforms and online retailing have helped mitigate these challenges to some extent, enabling consumers to access medical foods conveniently.

The Vitamins and Minerals segment is expected to be the largest during the forecast period

The growth of the vitamins and minerals segment in the medical food market is primarily driven by increasing awareness of nutritional deficiencies and their impact on health. As people become more health-conscious, there's a growing demand for targeted nutritional solutions to address specific health conditions. Vitamins and minerals play crucial roles in supporting various bodily functions, making them essential components of medical foods designed to manage conditions like malnutrition, metabolic disorders, and chronic diseases. Moreover, advancements in research and development have led to the formulation of specialized products tailored to meet specific nutritional needs, further fueling segment growth.

The Chronic conditions segment is expected to have the highest CAGR during the forecast period

The growth in the chronic conditions segment of the medical food market can be attributed to several factors. The increasing prevalence of chronic diseases such as diabetes, cardiovascular disorders, and gastrointestinal ailments is driving demand for specialized nutrition tailored to manage these conditions effectively. Advancements in medical research have led to the development of innovative formulations specifically designed to address the nutritional needs of individuals with chronic illnesses. Additionally, rising awareness among both healthcare professionals and patients about the role of nutrition in managing chronic conditions is fuelling market expansion.

Region with largest share:

In recent years, North America has experienced significant growth in the medical food market. This expansion can be attributed to several factors, including increasing awareness about the importance of nutritional therapies in managing chronic diseases like diabetes, Alzheimer's, and metabolic disorders. Additionally, advancements in medical research and technology have led to the development of innovative medical food products tailored to address specific health conditions. Moreover, the aging population in North America has contributed to the rising demand for products that support healthy aging and manage age-related ailments.

Region with highest CAGR:

The Asia-Pacific region has witnessed significant growth in the medical food market due to several factors. Increasing awareness about health and nutrition, the rising prevalence of chronic diseases, and a growing aging population are driving the demand for specialized nutritional products. Additionally, advancements in healthcare infrastructure and rising disposable incomes are facilitating greater access to medical foods. Moreover, the region's diverse dietary habits and cultural preferences are fueling innovation in product development to cater to specific dietary needs.

Key players in the market

Some of the key players in Medical Foods market include Abbott Laboratories, Ajinomoto Cambrooke Inc, Alfasigma S.p.A., BioMarin Pharmaceutical, Cerecin Inc, Danone S.A., Fresenius SE & Co. KGaA, Mead Johnson, Meiji Holdings and Co Ltd, Metagenics Inc, Nestle S.A., Primus Pharmaceuticals Inc and Reckitt Benckiser Group plc.

Key Developments:

In May 2024, Danone has struck a deal to acquire Functional Formularies, a US whole foods tube-feeding business. The France-headquartered dairy giant has snapped up the Ohio-based company from private-equity business Swander Pace Capital for an undisclosed fee. The move has extended Danone's medical nutrition portfolio, through which it develops products for people with special medical needs, adding to its enteral tube-feeding ranges.

In January 2024, Abbott, a global leader in science-based nutrition, announced the launch of its new PROTALITY(TM) brand. The high-protein nutrition shake is the first product in this line to support the growing number of adults interested in pursuing weight loss while maintaining muscle mass and good nutrition.

Products Covered:

  • Oral Rehydration Products
  • Nutritionally Complete Formulas
  • Nutritionally Incomplete Formulas

Route of Administrations Covered:

  • Oral
  • Enteral

Sales Channels Covered:

  • Supermarkets & Hypermarkets
  • Retail Pharmacies
  • Drugs Stores
  • Online Sales
  • Institutional Sales (Hospital Pharmacies)

Nutritional Ingredients Covered:

  • Proteins
  • Vitamins and Minerals
  • Isoflavones
  • Omega-3
  • Phytosterols

Forms Covered:

  • Bars
  • Gels
  • Liquid
  • Powder
  • Tablets & Capsules
  • Other Forms

Age Groups Covered:

  • Adults
  • Adolescent
  • Weaning
  • Infants

Applications Covered:

  • Sleep Management
  • Neuro-Degenerative Disorders
  • Maple Syrup Urine Disease (MSUD)
  • Diabetes (Diabetic Neuropathy)
  • Cancer (Chemotherapy-Induced Diarrhea)
  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Alzheimer's Disease
  • Chronic Conditions
  • Depression
  • Inborn Errors of Metabolism
  • Minimal Hepatic Encephalopathy
  • Neurological & Psychological Disorders
  • Nutritional Deficiency
  • Obesity and Hypertension
  • Ophthalmology
  • Pathogen Related Infections
  • Urea Cycle Disorders
  • Orphan Diseases
  • Tyrosinemia Types I And II
  • Propionic Acidemia
  • Pain Management
  • Organic Acidurias
  • Methylmalonic Acidemia
  • Isovaleric Acidemia
  • Homocystinuria
  • Gastrointestinal Disorders

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Medical Foods Market, By Product

  • 5.1 Introduction
  • 5.2 Oral Rehydration Products
  • 5.3 Nutritionally Complete Formulas
  • 5.4 Nutritionally Incomplete Formulas

6 Global Medical Foods Market, By Route of Administration

  • 6.1 Introduction
  • 6.2 Oral
  • 6.3 Enteral

7 Global Medical Foods Market, By Sales Channel

  • 7.1 Introduction
  • 7.2 Supermarkets & Hypermarkets
  • 7.3 Retail Pharmacies
  • 7.4 Drugs Stores
  • 7.5 Online Sales
  • 7.6 Institutional Sales (Hospital Pharmacies)

8 Global Medical Foods Market, By Nutritional Ingredient

  • 8.1 Introduction
  • 8.2 Proteins
  • 8.3 Vitamins and Minerals
  • 8.4 Isoflavones
  • 8.5 Omega-3
  • 8.6 Phytosterols

9 Global Medical Foods Market, By Form

  • 9.1 Introduction
  • 9.2 Bars
  • 9.3 Gels
  • 9.4 Liquid
  • 9.5 Powder
  • 9.6 Tablets & Capsules
  • 9.7 Other Forms

10 Global Medical Foods Market, By Age Group

  • 10.1 Introduction
  • 10.2 Adults
  • 10.3 Adolescent
  • 10.4 Weaning
  • 10.5 Infants

11 Global Medical Foods Market, By Application

  • 11.1 Introduction
  • 11.2 Sleep Management
  • 11.3 Neuro-Degenerative Disorders
  • 11.4 Maple Syrup Urine Disease (MSUD)
  • 11.5 Diabetes (Diabetic Neuropathy)
  • 11.6 Cancer (Chemotherapy-Induced Diarrhea)
  • 11.7 Attention Deficit Hyperactivity Disorder (ADHD)
  • 11.8 Alzheimer's Disease
  • 11.9 Chronic Conditions
  • 11.10 Depression
  • 11.11 Inborn Errors of Metabolism
  • 11.12 Minimal Hepatic Encephalopathy
  • 11.13 Neurological & Psychological Disorders
  • 11.14 Nutritional Deficiency
  • 11.15 Obesity and Hypertension
  • 11.16 Ophthalmology
  • 11.17 Pathogen Related Infections
  • 11.18 Urea Cycle Disorders
  • 11.19 Orphan Diseases
    • 11.19.1 Eosinophilic Esophagitis
    • 11.19.2 Phenylketonuria
    • 11.19.3 Food Protein-Induced Enterocolitis Syndrome (FPIES)
  • 11.20 Tyrosinemia Types I And II
  • 11.21 Propionic Acidemia
  • 11.22 Pain Management
  • 11.23 Organic Acidurias
  • 11.24 Methylmalonic Acidemia
  • 11.25 Isovaleric Acidemia
  • 11.26 Homocystinuria
  • 11.27 Gastrointestinal Disorders

12 Global Medical Foods Market, By Geography

  • 12.1 Introduction
  • 12.2 North America
    • 12.2.1 US
    • 12.2.2 Canada
    • 12.2.3 Mexico
  • 12.3 Europe
    • 12.3.1 Germany
    • 12.3.2 UK
    • 12.3.3 Italy
    • 12.3.4 France
    • 12.3.5 Spain
    • 12.3.6 Rest of Europe
  • 12.4 Asia Pacific
    • 12.4.1 Japan
    • 12.4.2 China
    • 12.4.3 India
    • 12.4.4 Australia
    • 12.4.5 New Zealand
    • 12.4.6 South Korea
    • 12.4.7 Rest of Asia Pacific
  • 12.5 South America
    • 12.5.1 Argentina
    • 12.5.2 Brazil
    • 12.5.3 Chile
    • 12.5.4 Rest of South America
  • 12.6 Middle East & Africa
    • 12.6.1 Saudi Arabia
    • 12.6.2 UAE
    • 12.6.3 Qatar
    • 12.6.4 South Africa
    • 12.6.5 Rest of Middle East & Africa

13 Key Developments

  • 13.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 13.2 Acquisitions & Mergers
  • 13.3 New Product Launch
  • 13.4 Expansions
  • 13.5 Other Key Strategies

14 Company Profiling

  • 14.1 Abbott Laboratories
  • 14.2 Ajinomoto Cambrooke Inc
  • 14.3 Alfasigma S.p.A.
  • 14.4 BioMarin Pharmaceutical
  • 14.5 Cerecin Inc
  • 14.6 Danone S.A.
  • 14.7 Fresenius SE & Co. KGaA
  • 14.8 Mead Johnson
  • 14.9 Meiji Holdings and Co Ltd
  • 14.10 Metagenics Inc
  • 14.11 Nestle S.A.
  • 14.12 Primus Pharmaceuticals Inc
  • 14.13 Reckitt Benckiser Group plc

List of Tables

  • Table 1 Global Medical Foods Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Medical Foods Market Outlook, By Product (2022-2030) ($MN)
  • Table 3 Global Medical Foods Market Outlook, By Oral Rehydration Products (2022-2030) ($MN)
  • Table 4 Global Medical Foods Market Outlook, By Nutritionally Complete Formulas (2022-2030) ($MN)
  • Table 5 Global Medical Foods Market Outlook, By Nutritionally Incomplete Formulas (2022-2030) ($MN)
  • Table 6 Global Medical Foods Market Outlook, By Route of Administration (2022-2030) ($MN)
  • Table 7 Global Medical Foods Market Outlook, By Oral (2022-2030) ($MN)
  • Table 8 Global Medical Foods Market Outlook, By Enteral (2022-2030) ($MN)
  • Table 9 Global Medical Foods Market Outlook, By Sales Channel (2022-2030) ($MN)
  • Table 10 Global Medical Foods Market Outlook, By Supermarkets & Hypermarkets (2022-2030) ($MN)
  • Table 11 Global Medical Foods Market Outlook, By Retail Pharmacies (2022-2030) ($MN)
  • Table 12 Global Medical Foods Market Outlook, By Drugs Stores (2022-2030) ($MN)
  • Table 13 Global Medical Foods Market Outlook, By Online Sales (2022-2030) ($MN)
  • Table 14 Global Medical Foods Market Outlook, By Institutional Sales (Hospital Pharmacies) (2022-2030) ($MN)
  • Table 15 Global Medical Foods Market Outlook, By Nutritional Ingredient (2022-2030) ($MN)
  • Table 16 Global Medical Foods Market Outlook, By Proteins (2022-2030) ($MN)
  • Table 17 Global Medical Foods Market Outlook, By Vitamins and Minerals (2022-2030) ($MN)
  • Table 18 Global Medical Foods Market Outlook, By Isoflavones (2022-2030) ($MN)
  • Table 19 Global Medical Foods Market Outlook, By Omega-3 (2022-2030) ($MN)
  • Table 20 Global Medical Foods Market Outlook, By Phytosterols (2022-2030) ($MN)
  • Table 21 Global Medical Foods Market Outlook, By Form (2022-2030) ($MN)
  • Table 22 Global Medical Foods Market Outlook, By Bars (2022-2030) ($MN)
  • Table 23 Global Medical Foods Market Outlook, By Gels (2022-2030) ($MN)
  • Table 24 Global Medical Foods Market Outlook, By Liquid (2022-2030) ($MN)
  • Table 25 Global Medical Foods Market Outlook, By Powder (2022-2030) ($MN)
  • Table 26 Global Medical Foods Market Outlook, By Tablets & Capsules (2022-2030) ($MN)
  • Table 27 Global Medical Foods Market Outlook, By Other Forms (2022-2030) ($MN)
  • Table 28 Global Medical Foods Market Outlook, By Age Group (2022-2030) ($MN)
  • Table 29 Global Medical Foods Market Outlook, By Adults (2022-2030) ($MN)
  • Table 30 Global Medical Foods Market Outlook, By Adolescent (2022-2030) ($MN)
  • Table 31 Global Medical Foods Market Outlook, By Weaning (2022-2030) ($MN)
  • Table 32 Global Medical Foods Market Outlook, By Infants (2022-2030) ($MN)
  • Table 33 Global Medical Foods Market Outlook, By Application (2022-2030) ($MN)
  • Table 34 Global Medical Foods Market Outlook, By Sleep Management (2022-2030) ($MN)
  • Table 35 Global Medical Foods Market Outlook, By Neuro-Degenerative Disorders (2022-2030) ($MN)
  • Table 36 Global Medical Foods Market Outlook, By Maple Syrup Urine Disease (MSUD) (2022-2030) ($MN)
  • Table 37 Global Medical Foods Market Outlook, By Diabetes (Diabetic Neuropathy) (2022-2030) ($MN)
  • Table 38 Global Medical Foods Market Outlook, By Cancer (Chemotherapy-Induced Diarrhea) (2022-2030) ($MN)
  • Table 39 Global Medical Foods Market Outlook, By Attention Deficit Hyperactivity Disorder (ADHD) (2022-2030) ($MN)
  • Table 40 Global Medical Foods Market Outlook, By Alzheimer's Disease (2022-2030) ($MN)
  • Table 41 Global Medical Foods Market Outlook, By Chronic Conditions (2022-2030) ($MN)
  • Table 42 Global Medical Foods Market Outlook, By Depression (2022-2030) ($MN)
  • Table 43 Global Medical Foods Market Outlook, By Inborn Errors of Metabolism (2022-2030) ($MN)
  • Table 44 Global Medical Foods Market Outlook, By Minimal Hepatic Encephalopathy (2022-2030) ($MN)
  • Table 45 Global Medical Foods Market Outlook, By Neurological & Psychological Disorders (2022-2030) ($MN)
  • Table 46 Global Medical Foods Market Outlook, By Nutritional Deficiency (2022-2030) ($MN)
  • Table 47 Global Medical Foods Market Outlook, By Obesity and Hypertension (2022-2030) ($MN)
  • Table 48 Global Medical Foods Market Outlook, By Ophthalmology (2022-2030) ($MN)
  • Table 49 Global Medical Foods Market Outlook, By Pathogen Related Infections (2022-2030) ($MN)
  • Table 50 Global Medical Foods Market Outlook, By Urea Cycle Disorders (2022-2030) ($MN)
  • Table 51 Global Medical Foods Market Outlook, By Orphan Diseases (2022-2030) ($MN)
  • Table 52 Global Medical Foods Market Outlook, By Eosinophilic Esophagitis (2022-2030) ($MN)
  • Table 53 Global Medical Foods Market Outlook, By Phenylketonuria (2022-2030) ($MN)
  • Table 54 Global Medical Foods Market Outlook, By Food Protein-Induced Enterocolitis Syndrome (FPIES) (2022-2030) ($MN)
  • Table 55 Global Medical Foods Market Outlook, By Tyrosinemia Types I And II (2022-2030) ($MN)
  • Table 56 Global Medical Foods Market Outlook, By Propionic Acidemia (2022-2030) ($MN)
  • Table 57 Global Medical Foods Market Outlook, By Pain Management (2022-2030) ($MN)
  • Table 58 Global Medical Foods Market Outlook, By Organic Acidurias (2022-2030) ($MN)
  • Table 59 Global Medical Foods Market Outlook, By Methylmalonic Acidemia (2022-2030) ($MN)
  • Table 60 Global Medical Foods Market Outlook, By Isovaleric Acidemia (2022-2030) ($MN)
  • Table 61 Global Medical Foods Market Outlook, By Homocystinuria (2022-2030) ($MN)
  • Table 62 Global Medical Foods Market Outlook, By Gastrointestinal Disorders (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.